搜索结果

Search Results for " bortezomib "

抑制剂 & 化合物

天然产物

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T2399	Bortezomib Radiciol,NSC 681239,硼替佐米,MG 341,DPBA,Brotezamide,LDP 341	Apoptosis; NF-κB; Proteasome; Autophagy	Apoptosis; Autophagy; NF-κB; Proteases/Proteasome; Ubiquitination
	Bortezomib (LDP 341) 是一种 20S 蛋白酶体抑制剂 (Ki=0.6 nM)，具有可逆性和选择性。Bortezomib 具有抗肿瘤活性，可以抑制 NF-κB，可破坏细胞周期、诱导细胞凋亡。
T10061	(1S,2S)-Bortezomib Bortezomib,硼替佐米(1S,2S)	Proteasome	Proteases/Proteasome; Ubiquitination
	(1S,2S)-Bortezomib (Bortezomib) 是 Bortezomib 的对映异构体。 Bortezomib 是一种可逆的选择性蛋白酶体抑制剂，对 20S 蛋白酶体的 Ki 为 0.6 nM。
T7854	Bortezomib-pinanediol	Proteasome	Proteases/Proteasome; Ubiquitination
	Bortezomib-pinanediol 是一种蛋白酶体抑制剂。是硼替佐米的前药。
T3971	CASIN Pirl1-related Compound 2	CDK; STAT; Ras	Cell Cycle/Checkpoint; GPCR/G Protein; JAK/STAT signaling; MAPK; Stem Cells
	CASIN (Pirl1-related Compound 2) 是选择性GTPase Cdc42抑制剂，IC50值是 2 uM。
T24130	HCI-2184 HCI2184,HCI 2184
	HCI-2184 is an inhibitor of AXL kinase and Nek2 that acts by successfully mitigating drug resistance in bortezomib-resistant multiple myeloma.
T69983	Ixazomib citrate EtOH
	Ixazomib citrate, also known as MLN9708, is a prodrug of Ixazomib (MMLN-2238). MLN9708 is an orally bioavailable second generation proteasome inhibitor (PI) with potential antineoplastic activity. MLN9708, after hydrolyzing to pharmacologically active MLN2238 (ixazomib), is a next-generation proteasome inhibitor with demonstrated preclinical and clinical antimyeloma activity. MLN9708, compared with bortezomib, has improved pharmacokinetics, pharmacodynamics, and antitumor activity in preclinic...
T37581	SCIO 469 hydrochloride
	Selective, ATP-competitive p38 inhibitor (IC50 = 9 nM for p38α in vitro). Displays approximately 10-fold selectivity for p38α over p38β and 2000-fold selectivity for p38α over 20 other kinases. Reduces p38α phosphorylation in multiple myeloma cells in vitro and in vivo; activity results in decreased tumor burden and angiogenesis in murine models of multiple myeloma. Also enhances bortezomib-induced cytotoxicity against multiple myeloma cells. Hideshima et al (2004) p38 MAPK inhibition enhances P...
T37068	NR-160
	NR-160 is an inhibitor of histone deacetylase 6 (HDAC6; IC50= 0.03 μM).1It is selective for HDAC6 over HDAC1, -2, -3, -4, and -8 (IC50s = 5.18, 2.26, 8.48, 55.4, and 14.7 μM, respectively). NR-160 is cytotoxic against a panel of seven cancer cell lines (IC50s = 22.5-51.8 μM). It enhances cytotoxicity induced by bortezomib in HL-60 cells, as well as cytotoxicity induced by epirubicin or daunorubicin in CCRF-HSB-2 T cell acute lymphoblastic leukemia cells.
T69288	CEP-7055
	CEP-18770 is an orally bioavailable synthetic P2 threonine boronic acid inhibitor of the chymotrypsin-like activity of the proteasome, with potential antineoplastic activity. Proteasome inhibitor CEP 18770 represses the proteasomal degradation of a variety of proteins, including inhibitory kappaBalpha (IkappaBalpha), resulting in the cytoplasmic sequestration of the transcription factor NF-kappaB; inhibition of NF-kappaB nuclear translocation and transcriptional up-regulation of a variety of cel...
T68306	INCB16562
	INCB16562 is a novel, selective, and orally bioavailable small-molecule inhibitor of JAK1 and JAK2 markedly selective over JAK3. Treatment of myeloma cells with INCB16562 potently inhibited interleukin-6 (IL-6)-induced phosphorylation of STAT3. INCB16562 abrogated the protective effects of recombinant cytokines or bone marrow stromal cells and sensitized myeloma cells to cell death by exposure to dexamethasone, melphalan, or bortezomib. Oral administration of INCB16562 antagonized the growth of ...

化合物

Bortezomib

Cat.No: T2399

Synonym: Radiciol,NSC 681239,硼替佐米,MG 341,DPBA,Brotezamide,LDP 341

Target: Apoptosis, NF-κB, Proteasome, Autophagy

(1S,2S)-Bortezomib

Cat.No: T10061

Synonym: Bortezomib,硼替佐米(1S,2S)

Target: Proteasome

Bortezomib-pinanediol

Cat.No: T7854

Synonym:

Target: Proteasome

CASIN

Cat.No: T3971

Synonym: Pirl1-related Compound 2

Target: CDK, STAT, Ras

HCI-2184

Cat.No: T24130

Synonym: HCI2184,HCI 2184

Target:

Ixazomib citrate EtOH

Cat.No: T69983

Synonym:

Target:

SCIO 469 hydrochloride

Cat. No.	Product Name	Target	Signaling Pathways
TCS2170	2,5-Dihydroxyacetophenone Quinacetophenone,2-Acetylhydroquinone,2-5-dihydroxyacetophenone,2 '，5'-二羟基苯乙酮,Acetylhydroquinone,2,5-二羟基苯乙酮,DHAP	ERK; NF-κB; Tyrosinase	MAPK; NF-κB; Proteases/Proteasome
	2,5-Dihydroxyacetophenone (Quinacetophenone) 是从熟地黄中分离出的一种天然产物，通过阻断 ERK1/2和 NF-κB 信号通路，抑制活化巨噬细胞中炎症介质的产生。

天然产物

2,5-Dihydroxyacetophenone

Cat.No: TCS2170

Synonym: Quinacetophenone,2-Acetylhydroquinone,2-5-dihydroxyacetophenone,2 '，5'-二羟基苯乙酮,Acetylhydroquinone,2,5-二羟基苯乙酮,DHAP

Target: ERK, NF-κB, Tyrosinase

* 搜索：		* 机关/企业：
* 邮箱：		* 电话：
备注：
验证码：

搜索结果

抑制剂 & 化合物

天然产物

提交您的定制咨询

化合物

天然产物